Market Overview

UPDATE: Morgan Stanley Reiterates On Walgreen Company Ahead Of February Sales Report

Related WAG
CVS Photo Site Reportedly Hacked: Everything You Need To Know
IPO Outlook: API-Focused Software Tech Company Apigee Is A Silent Growth Story

In a report published Monday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating on Walgreen Company (NYSE: WAG), but removed the $68.00 price target.

In the report, Morgan Stanley noted, “WAG is scheduled to report February sales on Wednesday, March 5th before market open. February sales are the final month of WAG's 2QFY14 quarter. We expect a total sales comp of 4.8% y/y (vs. cons. of 4.6%), with no calendar day shift impact, up from an adj. comp of 3.2% in January. The February total sales comp reflects a pharmacy sales comp estimate of 6.3% vs. consensus of 6.1%, and a front-end comp estimate of 2.6% vs. consensus of 2.0%.”

Walgreen Company closed on Friday at $67.95.

Latest Ratings for WAG

Dec 2014BarclaysMaintainsEqual-weight
Dec 2014JP MorganMaintainsOverweight
Dec 2014SunTrust Robinson HumphreyDowngradesBuyNeutral

View More Analyst Ratings for WAG
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Ricky R. GoldwasserAnalyst Color Price Target Analyst Ratings


Related Articles (WAG)

View Comments and Join the Discussion!

Get Benzinga's Newsletters